Literature DB >> 22864628

Diagnosis of 22q11.2 deletion syndrome and artemis deficiency in two children with T-B-NK+ immunodeficiency.

Jennifer Heimall1, Michael Keller, Rushani Saltzman, Nancy Bunin, Donna McDonald-McGinn, Elaine Zakai, Jean-Pierre de Villartay, Despina Moshous, Barbara Ariue, Elizabeth A McCarthy, Blythe H Devlin, Suhag Parikh, Rebecca H Buckley, M Louise Markert.   

Abstract

Two infants are described who presented with 22q11.2 deletion and a T(-)B(-)NK(+) immune phenotype. For both infants, the initial diagnosis was athymia secondary to complete DiGeorge anomaly. The first infant underwent thymus transplantation but 6 months after transplantation had circulating thymus donor T cells; the patient did not develop recipient naïve T cells. Genetic analyses revealed that both patients had Artemis deficiency, a rare form of severe combined immunodeficiency (SCID). Both infants have subsequently undergone bone marrow transplantation. These cases illustrate the importance and paradox of differentiating SCID from complete DiGeorge anomaly because hematopoietic stem cell transplantation (HSCT) is the preferred treatment for SCID but is ineffective for complete DiGeorge anomaly. However, if the thymus is completely absent, donor stem cells from a HSCT would not be able to be educated.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22864628     DOI: 10.1007/s10875-012-9741-9

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  6 in total

1.  Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival.

Authors:  Laurie A Myers; Dhavalkumar D Patel; Jennifer M Puck; Rebecca H Buckley
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

Review 2.  Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes.

Authors:  Rebecca H Buckley
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

3.  DiGeorge anomaly in the absence of chromosome 22q11.2 deletion.

Authors:  Alan F Rope; Deborah L Cragun; Howard M Saal; Robert J Hopkin
Journal:  J Pediatr       Date:  2009-10       Impact factor: 4.406

4.  Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants.

Authors:  M Louise Markert; Blythe H Devlin; Marilyn J Alexieff; Jie Li; Elizabeth A McCarthy; Stephanie E Gupton; Ivan K Chinn; Laura P Hale; Thomas B Kepler; Min He; Marcella Sarzotti; Michael A Skinner; Henry E Rice; Jeffrey C Hoehner
Journal:  Blood       Date:  2007-02-06       Impact factor: 22.113

Review 5.  Chromosome 22q11.2 deletion syndrome: DiGeorge syndrome/velocardiofacial Syndrome.

Authors:  Kathleen E Sullivan
Journal:  Immunol Allergy Clin North Am       Date:  2008-05       Impact factor: 3.479

6.  A founder mutation in Artemis, an SNM1-like protein, causes SCID in Athabascan-speaking Native Americans.

Authors:  Lanying Li; Despina Moshous; Yungui Zhou; Junhua Wang; Gang Xie; Eduardo Salido; Diana Hu; Jean-Pierre de Villartay; Morton J Cowan
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

  6 in total
  7 in total

1.  Positive Family History, Infection, Low Absolute Lymphocyte Count (ALC), and Absent Thymic Shadow: Diagnostic Clues for All Molecular Forms of Severe Combined Immunodeficiency (SCID).

Authors:  Laurie M McWilliams; Mary Dell Railey; Rebecca H Buckley
Journal:  J Allergy Clin Immunol Pract       Date:  2015-03-29

2.  Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency.

Authors:  Christopher C Dvorak; Amel Hassan; Mary A Slatter; Manfred Hönig; Arjan C Lankester; Rebecca H Buckley; Michael A Pulsipher; Jeffrey H Davis; Tayfun Güngör; Melissa Gabriel; Jacob H Bleesing; Nancy Bunin; Petr Sedlacek; James A Connelly; David F Crawford; Luigi D Notarangelo; Sung-Yun Pai; Jake Hassid; Paul Veys; Andrew R Gennery; Morton J Cowan
Journal:  J Allergy Clin Immunol       Date:  2014-08-07       Impact factor: 10.793

3.  22q and two: 22q11.2 deletion syndrome and coexisting conditions.

Authors:  Jennifer L Cohen; Terrence B Crowley; Daniel E McGinn; Carey McDougall; Marta Unolt; Michele P Lambert; Beverly S Emanuel; Elaine H Zackai; Donna M McDonald-McGinn
Journal:  Am J Med Genet A       Date:  2018-09-23       Impact factor: 2.802

Review 4.  Exploring the RNA Gap for Improving Diagnostic Yield in Primary Immunodeficiencies.

Authors:  Jed J Lye; Anthony Williams; Diana Baralle
Journal:  Front Genet       Date:  2019-12-11       Impact factor: 4.599

Review 5.  New genetic discoveries and primary immune deficiencies.

Authors:  Vivian Hernandez-Trujillo
Journal:  Clin Rev Allergy Immunol       Date:  2014-04       Impact factor: 10.817

Review 6.  Immunodeficiency in DiGeorge Syndrome and Options for Treating Cases with Complete Athymia.

Authors:  E Graham Davies
Journal:  Front Immunol       Date:  2013-10-31       Impact factor: 7.561

Review 7.  Hematopoietic Stem Cell Transplantation for DNA Double Strand Breakage Repair Disorders.

Authors:  Beata Wolska-Kuśnierz; Andrew R Gennery
Journal:  Front Pediatr       Date:  2020-01-15       Impact factor: 3.418

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.